In the framework of our European project CE4BIG, we have developed a collaboration with the European project CELIS, which is... View Article
Author Archives for Adeline Chauvigné
CELIS Challenges? Are you up to it?
19 May 2024In the framework of our European project CE4BIG, we have developed a collaboration with the European project CELIS, which is... View Article
GlioCure transforms into a Limited Liability Company and closes a new round of financing
GlioCure, a preclinical-drug-development company specialized in neuro-oncology, announced today that during a recent combined general meeting, its shareholders ratified transformation... View Article
GlioCure transforms into a Limited Liability Company and closes a new round of financing
19 May 2024GlioCure, a preclinical-drug-development company specialized in neuro-oncology, announced today that during a recent combined general meeting, its shareholders ratified transformation... View Article
Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
Valneva, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet... View Article
Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
19 May 2024Valneva, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet... View Article
Valneva Switches Focus to Bilateral Discussions to Supply its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
Valneva Switches Focus to Bilateral Discussions to Supply its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
19 May 2024Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
INRAE involved in a research project on non-hormonal female contraception
Accelerating Discovery for Non-Hormonal Contraceptives is one of the Grand Challenge programmes launched by the Bill & Melinda Gates Foundation... View Article
INRAE involved in a research project on non-hormonal female contraception
19 May 2024Accelerating Discovery for Non-Hormonal Contraceptives is one of the Grand Challenge programmes launched by the Bill & Melinda Gates Foundation... View Article
New member | Wetan
Wetan supports startups leaders or project leaders who need to finance their project successfully. The compant helps them build a... View Article
New member | Wetan
19 May 2024Wetan supports startups leaders or project leaders who need to finance their project successfully. The compant helps them build a... View Article
New member | LaFleur by DelleD
While the experimentation of the medical use of cannabis framed by the National Agency for Medicines began in France on... View Article
New member | LaFleur by DelleD
19 May 2024While the experimentation of the medical use of cannabis framed by the National Agency for Medicines began in France on... View Article
Update on XENOTHERA’s news
In March, XENOTHERA went on digging its wake to analyze the clinical efficacy of XAV-19. Marchwas the month for the... View Article
Update on XENOTHERA’s news
19 May 2024In March, XENOTHERA went on digging its wake to analyze the clinical efficacy of XAV-19. Marchwas the month for the... View Article
New member | Bioprox Healthcare
BIOPROX HEALTHCARE produces probiotics of bacterial origin belonging to about thirty different species mainly Lactobacillus (former genus name) and Bifidobacterium isolated from human... View Article
New member | Bioprox Healthcare
19 May 2024BIOPROX HEALTHCARE produces probiotics of bacterial origin belonging to about thirty different species mainly Lactobacillus (former genus name) and Bifidobacterium isolated from human... View Article
New member | Genourob
Genourob design, produce and commercialize medical devices for helping ACL tears diagnosis and for rehabilitation and fitness. Genourob has become the world... View Article
New member | Genourob
19 May 2024Genourob design, produce and commercialize medical devices for helping ACL tears diagnosis and for rehabilitation and fitness. Genourob has become the world... View Article